Tagged with pharmaceutical sales
SaxoTV
Neighbour: Shorting GSK as pharma stocks catch...
Joe Neighbour has been tracking GlaxoSmithKline, a big pharma stock that seems to be in a...
SaxoTV
Earnings Season: GSK will disappoint but pharma...
Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...
SaxoTV
Are high returns from marijuana companies just...
This week the New York Times, in an editorial, urged US lawmakers to legalise marijuana. Some...
SaxoTV
Berger: Biogen's healthy recovery
Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...
SaxoTV
Garnry: "Astra Zeneca shareholders blew it"
AstraZeneca’s stock price tumbled 14 percent on Monday morning after the company rejected...
SaxoTV
Astra Zeneca and Pfizer: Five things you need...
As the Astra Zeneca Pfizer deal gets more bad tempered and political, what are the side effects...
SaxoTV
Buying the biotech boost
Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...
SaxoTV
AstraZeneca finds Pfizer bid a bitter pill to...
The boss of British pharmaceutical giant AstraZeneca, Pascal Soriot, has been emphasising the...
SaxoTV
How did Johnson & Johnson beat expectations?
Johnson Johnson Co. pharmaceuticals division has pushed first quarter profits past analysts’...